| Product Code: ETC6753050 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Secukinumab Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Secukinumab Market Revenues & Volume, 2021 & 2031F |
3.3 China Secukinumab Market - Industry Life Cycle |
3.4 China Secukinumab Market - Porter's Five Forces |
3.5 China Secukinumab Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Secukinumab Market Revenues & Volume Share, By Drug Class, 2021 & 2031F |
3.7 China Secukinumab Market Revenues & Volume Share, By Demographic, 2021 & 2031F |
3.8 China Secukinumab Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.9 China Secukinumab Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.10 China Secukinumab Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 China Secukinumab Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of autoimmune diseases in China |
4.2.2 Growing awareness about the benefits of secukinumab therapy |
4.2.3 Favorable government policies supporting the use of advanced biologics in healthcare |
4.3 Market Restraints |
4.3.1 High cost associated with secukinumab treatment |
4.3.2 Limited access to specialized healthcare facilities in certain regions of China |
4.3.3 Stringent regulatory requirements for approval and reimbursement of biologic drugs |
5 China Secukinumab Market Trends |
6 China Secukinumab Market, By Types |
6.1 China Secukinumab Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Secukinumab Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 China Secukinumab Market Revenues & Volume, By Sensoready Pen, 2021- 2031F |
6.1.4 China Secukinumab Market Revenues & Volume, By Prefilled Syringe, 2021- 2031F |
6.1.5 China Secukinumab Market Revenues & Volume, By Powder for Solution, 2021- 2031F |
6.2 China Secukinumab Market, By Drug Class |
6.2.1 Overview and Analysis |
6.2.2 China Secukinumab Market Revenues & Volume, By Interleukin Inhibitors, 2021- 2031F |
6.2.3 China Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.3 China Secukinumab Market, By Demographic |
6.3.1 Overview and Analysis |
6.3.2 China Secukinumab Market Revenues & Volume, By Adult, 2021- 2031F |
6.3.3 China Secukinumab Market Revenues & Volume, By Pediatric, 2021- 2031F |
6.4 China Secukinumab Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 China Secukinumab Market Revenues & Volume, By Ankylosing Spondylitis, 2021- 2031F |
6.4.3 China Secukinumab Market Revenues & Volume, By Psoriatic Arthritis, 2021- 2031F |
6.4.4 China Secukinumab Market Revenues & Volume, By Plaque Psoriasis, 2021- 2031F |
6.4.5 China Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.5 China Secukinumab Market, By End-Users |
6.5.1 Overview and Analysis |
6.5.2 China Secukinumab Market Revenues & Volume, By Clinic, 2021- 2031F |
6.5.3 China Secukinumab Market Revenues & Volume, By Hospital, 2021- 2031F |
6.5.4 China Secukinumab Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Secukinumab Market, By Distribution Channel |
6.6.1 Overview and Analysis |
6.6.2 China Secukinumab Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.6.3 China Secukinumab Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.6.4 China Secukinumab Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 China Secukinumab Market Import-Export Trade Statistics |
7.1 China Secukinumab Market Export to Major Countries |
7.2 China Secukinumab Market Imports from Major Countries |
8 China Secukinumab Market Key Performance Indicators |
8.1 Number of healthcare facilities offering secukinumab therapy |
8.2 Rate of adoption of secukinumab compared to other biologic treatments |
8.3 Patient satisfaction and adherence rates with secukinumab therapy |
9 China Secukinumab Market - Opportunity Assessment |
9.1 China Secukinumab Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Secukinumab Market Opportunity Assessment, By Drug Class, 2021 & 2031F |
9.3 China Secukinumab Market Opportunity Assessment, By Demographic, 2021 & 2031F |
9.4 China Secukinumab Market Opportunity Assessment, By Application, 2021 & 2031F |
9.5 China Secukinumab Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.6 China Secukinumab Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 China Secukinumab Market - Competitive Landscape |
10.1 China Secukinumab Market Revenue Share, By Companies, 2024 |
10.2 China Secukinumab Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here